Selisa Thomas is currently the Director of Clinical Operations at Eli Lilly and Company, a position held since 2024. Prior to this role, Selisa served as a Global Clinical Trial Manager at Amgen from 2020 to 2021 and has held various positions including Regional Clinical Trial Manager at DOCS and Senior Project Associate at PRA Health Sciences. Selisa’s extensive experience in clinical trials spans multiple therapeutic areas, including oncology and nephrology. Selisa earned a Bachelor's Degree in Evolutionary Biology from the University of California, Davis, from 1995 to 1999.
This person is not in any teams
This person is not in any offices